Literature DB >> 19797601

Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases.

C Anandan1, R Gupta, C R Simpson, C Fischbacher, A Sheikh.   

Abstract

BACKGROUND: There are ongoing concerns about the quality of care provided to patients with allergic disorders in Scotland, but there are relatively few reliable data on the overall disease burden. We sought to: (1) describe the incidence, prevalence and outcome of allergic disorders; (2) estimate healthcare burden and costs; and (3) investigate ethnic variations in the epidemiology and outcomes from allergic disorders in Scotland. DATA SOURCES: national surveys; primary care data; prescribing and medication data; hospital admissions data and mortality data.
RESULTS: Allergic disorders are extremely common in Scotland, affecting about one in three of the population at some time in their lives. Incidence was highest for eczema (10.2 per 1000 registered patients). Over 4% of all GP consultations and 1.5% of hospital admissions were for allergic disorders. There were 100 asthma deaths in 2005 (20 per million people). Direct healthcare costs for allergic disorders were an estimated pound130 million per year, the majority of these being incurred in primary care and related to asthma.
CONCLUSIONS: Allergic disorders are common in Scotland and given the very high proportion of children now affected, the high disease burden associated with these conditions is likely to persist for many decades.

Entities:  

Mesh:

Year:  2009        PMID: 19797601      PMCID: PMC2755331          DOI: 10.1258/jrsm.2009.090027

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  12 in total

Review 1.  Lessons for management of anaphylaxis from a study of fatal reactions.

Authors:  R S Pumphrey
Journal:  Clin Exp Allergy       Date:  2000-08       Impact factor: 5.018

2.  A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom.

Authors:  Michael M Peng; Hershel Jick
Journal:  Arch Intern Med       Date:  2004-02-09

3.  Inadequacies in UK primary care allergy services: national survey of current provisions and perceptions of need.

Authors:  M L Levy; D Price; X Zheng; C Simpson; P Hannaford; A Sheikh
Journal:  Clin Exp Allergy       Date:  2004-04       Impact factor: 5.018

4.  Change in prevalence of IgE sensitization and mean total IgE with age and cohort.

Authors:  Deborah Jarvis; Christina Luczynska; Susan Chinn; James Potts; Jordi Sunyer; Christer Janson; Cecilie Svanes; Nino Künzli; Bénédicte Leynaert; Joachim Heinrich; Marjan Kerkhof; Ursula Ackermann-Liebrich; Josep M Antó; Isa Cerveri; Roberto de Marco; Thorarinn Gislason; Françoise Neukirch; Paul Vermeire; Matthias Wjst; Peter Burney
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

5.  NHS allergy services in the UK: proposals to improve allergy care.

Authors:  Pamela W Ewan; Stephen R Durham
Journal:  Clin Med (Lond)       Date:  2002 Mar-Apr       Impact factor: 2.659

6.  Burden of allergic disease in the UK: secondary analyses of national databases.

Authors:  R Gupta; A Sheikh; D P Strachan; H R Anderson
Journal:  Clin Exp Allergy       Date:  2004-04       Impact factor: 5.018

7.  Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices.

Authors:  Y S Punekar; A Sheikh
Journal:  Clin Exp Allergy       Date:  2009-04-17       Impact factor: 5.018

8.  Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study.

Authors:  Samantha Walker; Saba Khan-Wasti; Monica Fletcher; Paul Cullinan; Jessica Harris; Aziz Sheikh
Journal:  J Allergy Clin Immunol       Date:  2007-06-08       Impact factor: 10.793

Review 9.  Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders.

Authors:  C Anandan; C R Simpson; C Fischbacher; A Sheikh
Journal:  Clin Exp Allergy       Date:  2006-07       Impact factor: 5.018

10.  Record linked retrospective cohort study of 4.6 million people exploring ethnic variations in disease: myocardial infarction in South Asians.

Authors:  C M Fischbacher; R Bhopal; C Povey; M Steiner; J Chalmers; G Mueller; J Jamieson; D Knowles
Journal:  BMC Public Health       Date:  2007-07-05       Impact factor: 3.295

View more
  30 in total

Review 1.  Telehealthcare for asthma: a Cochrane review.

Authors:  Susannah McLean; David Chandler; Ulugbek Nurmatov; Joseph Liu; Claudia Pagliari; Josip Car; Aziz Sheikh
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

2.  Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study.

Authors:  Belén de la Hoz Caballer; Mercedes Rodríguez; Juan Fraj; Inmaculada Cerecedo; Darío Antolín-Amérigo; Carlos Colás
Journal:  Am J Rhinol Allergy       Date:  2012 Sep-Oct       Impact factor: 2.467

Review 3.  House dust mite avoidance measures for perennial allergic rhinitis.

Authors:  Aziz Sheikh; Brian Hurwitz; Ulugbek Nurmatov; Constant Paul van Schayck
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

Review 4.  Atopic Dermatitis: Epidemiology and Clinical Phenotypes.

Authors:  Annunziata Raimondo; Serena Lembo
Journal:  Dermatol Pract Concept       Date:  2021-10-01

5.  Allergy in Irish adults: a survey of referrals and outcomes at a major centre.

Authors:  N P Conlon; A Abramovitch; G Murray; A O'Hanrahan; D Wallace; K Holohan; N Cleary; C Feighery; C Lee-Brennan
Journal:  Ir J Med Sci       Date:  2014-04-18       Impact factor: 1.568

6.  Developing and testing of a screening tool to predict people without IgE-mediated allergy: a quantitative analysis of the predictive value of a screening tool.

Authors:  Victoria S Hammersley; Jessica Harris; Aziz Sheikh; Emma Davidson; Samantha Walker
Journal:  Br J Gen Pract       Date:  2017-02-28       Impact factor: 5.386

7.  Challenges of harmonising data from UK national health surveys: a case study of attempts to estimate the UK prevalence of asthma.

Authors:  Bright I Nwaru; Mome Mukherjee; Ramyani P Gupta; Angela Farr; Martin Heaven; Andrew Stoddart; Amrita Bandyopadhyay; Deborah Fitzsimmons; Michael Shields; Ceri Phillips; George Chamberlain; Colin Fischbacher; Christopher Dibben; Chantelle Aftab; Colin R Simpson; Ronan Lyons; David Strachan; Gwyneth A Davies; Brian McKinstry; Aziz Sheikh
Journal:  J R Soc Med       Date:  2015-10-02       Impact factor: 5.344

Review 8.  Telehealthcare for asthma.

Authors:  Susannah McLean; David Chandler; Ulugbek Nurmatov; Joseph Liu; Claudia Pagliari; Josip Car; Aziz Sheikh
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

9.  Hormonal contraceptives and asthma in women of reproductive age: analysis of data from serial national Scottish Health Surveys.

Authors:  Bright I Nwaru; Aziz Sheikh
Journal:  J R Soc Med       Date:  2015-07-07       Impact factor: 5.344

10.  EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.

Authors:  Moises A Calderon; Pascal Demoly; Roy Gerth van Wijk; Jean Bousquet; Aziz Sheikh; Anthony Frew; Glenis Scadding; Claus Bachert; Hans J Malling; Rudolph Valenta; Beatrice Bilo; Antonio Nieto; Cezmi Akdis; Jocelyne Just; Carmen Vidal; Eva M Varga; Emilio Alvarez-Cuesta; Barbara Bohle; Albrecht Bufe; Walter G Canonica; Victoria Cardona; Ronald Dahl; Alain Didier; Stephen R Durham; Peter Eng; Montserrat Fernandez-Rivas; Lars Jacobsen; Marek Jutel; Jörg Kleine-Tebbe; Ludger Klimek; Jan Lötvall; Carmen Moreno; Ralph Mosges; Antonella Muraro; Bodo Niggemann; Giovanni Pajno; Giovanni Passalacqua; Oliver Pfaar; Sabina Rak; Gianenrico Senna; Gabriela Senti; Erkka Valovirta; Marianne van Hage; Johannes C Virchow; Ulrich Wahn; Nikolaos Papadopoulos
Journal:  Clin Transl Allergy       Date:  2012-10-30       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.